Literature DB >> 18175399

Dysautonomia and cognitive dysfunction in Parkinson's disease.

Werner Poewe1.   

Abstract

Nonmotor symptoms have recently become a focus of renewed clinical interest and research in Parkinson's disease (PD). Autonomic and cognitive dysfunction are among the most prevalent of these nonmotor aspects of the disease. Although exact clinico-pathological correlations have not been established, alpha-synuclein pathology with Lewy body formation in the central and peripheral autonomic nervous system as well as in neocortical areas are generally believed to be driving factors for autonomic failure and cognitive decline in PD. Recent pathological and clinical studies have suggested greater prevalence of clinical dysautonomia and cardiac sympathetic denervation in PD dementia and dementia with Lewy bodies as compared with PD without dementia. This raises the possibility that spread of synuclein pathology to involve neocortical areas producing cognitive decline could be somehow linked to involvement of the autonomic nervous system in PD.

Entities:  

Mesh:

Year:  2007        PMID: 18175399     DOI: 10.1002/mds.21681

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  19 in total

1.  Parasympathetic and sympathetic nervous systems interactively predict change in cognitive functioning in midlife adults.

Authors:  Erik L Knight; Ryan J Giuliano; Sean W Shank; Megan M Clarke; David M Almeida
Journal:  Psychophysiology       Date:  2020-06-29       Impact factor: 4.016

2.  Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.

Authors:  E Y Uc; M P McDermott; K S Marder; S W Anderson; I Litvan; P G Como; P Auinger; K L Chou; J C Growdon
Journal:  Neurology       Date:  2009-11-03       Impact factor: 9.910

Review 3.  The practical management of cognitive impairment and psychosis in the older Parkinson's disease patient.

Authors:  John V Hindle
Journal:  J Neural Transm (Vienna)       Date:  2013-02-22       Impact factor: 3.575

4.  Cerebral microbleeds in patients with Parkinson's disease.

Authors:  Jee Hyun Ham; Han Yi; Mun Kyung Sunwoo; Jin Yong Hong; Young H Sohn; Phil Hyu Lee
Journal:  J Neurol       Date:  2014-06-12       Impact factor: 4.849

5.  Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease.

Authors:  Xiao-Lu Niu; Li Liu; Zhi-Xiu Song; Qing Li; Zhi-Hua Wang; Jian-Long Zhang; He-Hua Li
Journal:  J Neural Transm (Vienna)       Date:  2016-09-02       Impact factor: 3.575

Review 6.  Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson's disease.

Authors:  Kathleen A Maguire-Zeiss; Howard J Federoff
Journal:  J Neural Transm (Vienna)       Date:  2010-06-12       Impact factor: 3.575

Review 7.  Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.

Authors:  Isidre Ferrer; Anna Martinez; Rosa Blanco; Ester Dalfó; Margarita Carmona
Journal:  J Neural Transm (Vienna)       Date:  2010-09-23       Impact factor: 3.575

8.  Autoimmune autonomic ganglionopathy with reversible cognitive impairment.

Authors:  Christopher H Gibbons; Justin Centi; Steven Vernino; Roy Freeman
Journal:  Arch Neurol       Date:  2011-12-12

Review 9.  Dementia and neuroimaging.

Authors:  Federica Agosta; Francesca Caso; Massimo Filippi
Journal:  J Neurol       Date:  2012-12-15       Impact factor: 4.849

10.  Lewy body dementia and Parkinson's disease with dementia.

Authors:  Richard Dodel; Ilona Csoti; Georg Ebersbach; Gerd Fuchs; Matthias Hahne; Wilfried Kuhn; Matthias Oechsner; Wolfgang Jost; Heinz Reichmann; Jörg B Schulz
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.